<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
    <link rel="stylesheet" href="../css/uswds.min.css">
    <link rel="stylesheet" href="../css/style.css">
    <link rel="stylesheet" href="css/uswds.min.css">
    <link rel="stylesheet" href="css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="/">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="/">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="/html/titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="/html/parts/21CFR522.html">Part 522
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 522.2670  Yohimbine.
                            </h3>
                            <p class="depth0"><em>(a)</em> Specifications. Each milliliter (mL) of solution contains 2 or 5 milligrams (mg) of yohimbine (as hydrochloride).</p><p class="depth0"><em>(b)</em> Sponsors. See sponsors in Sec. 510.600(c) of this chapter for use as in paragraph (c) of this section.</p><p class="depth0"><em>(1)</em> No. 059399 for use of in 2 mg/mL solution as in paragraph (c)(1) of this section.</p><p class="depth0"><em>(2)</em> No. 053923 for use of in 5 mg/mL solution as in paragraph (c)(2) of this section.</p><p class="depth0"><em>(c)</em> Conditions of use--(1) Dogs--(i) Amount. Administer 0.05 mg per pound (0.11 mg per kilogram) of body weight by intravenous injection.</p><p class="depth0"><em>(ii)</em> Indications for use. To reverse the effects of xylazine in dogs.</p><p class="depth0"><em>(iii)</em> Limitations. Not for use in food-producing animals. Federal law restricts this drug to use by or on the order of a licensed veterinarian.</p><p class="depth0"><em>(2)</em> Deer and elk--(i) Amount. Administer 0.2 to 0.3 mg per kilogram of body weight by intravenous injection.</p><p class="depth0"><em>(ii)</em> Indications for use. A s an antagonist to xylazine sedation in free ranging or confined members of the family Cervidae (deer and elk).</p><p class="depth0"><em>(iii)</em> Limitations. Do not use in domestic food-producing animals. Do not use for 30 days before or during hunting season. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[79 FR 74020, Dec. 15, 2014, as amended at 80 FR 13230, Mar. 13, 2015]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>. Code available <a href="#">on Github.</a></h5>
      </div>
    </div>
  </footer>
  </body>
</html>
